George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

Share Price Information for Enteq Tech (NTQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 8.50
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 1.00 (11.765%)
Open: 9.00
High: 9.00
Low: 9.00
Prev. Close: 9.00
NTQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Enteq Upstream plc

2 May 2012 16:15

RNS Number : 6084C
AIM
02 May 2012
 



ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Enteq Upstream plc ("Enteq" or the "Company")

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

The Courtyard

High Street

Ascot

Berkshire

SL5 7HP

 

COUNTRY OF INCORPORATION:

UK

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.enteq.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

Enteq was admitted to trading to AIM on 1 July 2011 with the intention of acquiring and consolidating companies providing specialist reach and recovery products and technologies to the international upstream oil and gas services market.

 

As a result of Enteq's proposed acquisition of substantially all of the operating assets and certain liabilities of XXT, Incorporated ("XXT"), admission has been sought as a reverse takeover pursuant to Rule 14 of the AIM Rules. XXT is based in California, USA and is an engineering company which has developed products to enhance the capabilities of measurement while drilling (MWD) systems. These technical products are sold to directional drilling oil and gas services companies, principally in North America.

 

Following admission, Enteq's main country of operation will be the USA

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

58,903,653 ordinary shares of 1p each

 

No shares will be held in treasury

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

Capital to be raised on admission: £42.0 million

 

Anticipated market capitalisation on admission: approximately £58.9 million

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

Approximately 5.5%

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

N/A

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Martin Gordon Perry (Chief Executive Officer)

Ian David Leaman (Chief Financial Officer and Company Secretary)

Raymond Garcia (Chief Operating Officer)

Neil William Warner (Non-Executive Chairman)

Robin Hunter Pinchbeck (Non-Executive Director)

Iain Stayton Paterson (Non-Executive Director)

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Before Admission:

Octopus Investments - 13.95%

Old Mutual Asset Managers - 9.97%

Hargreave Hale, Stockbrokers - 9.30%

Soros Fund Management - 9.30%

F&C Asset Management - 6.19%

Hermes Pensions Management - 5.98%

Artemis Investment Management - 5.47%

M&G Investment Management - 5.32%

Aviva Investors - 4.65%

Threadneedle Investments - 4.32%

Martin Gordon Perry - 4.19%

Jupiter Asset Management - 3.32%

Newlands Capital - 3.10%

 

At Admission:

Soros Fund Management - 9.16%

Old Mutual Asset Management - 7.28%

M&G Investment Management - 6.45%

Artemis Investment Management - 5.91%

Hargreave Hale, Stockbrokers - 5.09%

Legal & General Investment Management - 5.08%

Investec Asset Management - 4.48%

Insight Investment Management - 4.27%

Threadneedle Investments - 4.16%

Ruffer Investment Management - 3.85%

Octopus Investments - 3.77%

Hermes Pensions Management - 3.65%

F&C Asset Management - 3.15%

Fidelity Investments - 3.11%

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

Ian Leaman was appointed as the Company's Interim Chief Financial Officer on 18 November 2011 pursuant to an agreement for the provision of services between the Company and Leaman Advisory Ltd dated the same date. He was entitled to a fee of £20,000 plus VAT per month. His role as Interim Chief Financial Officer terminated on 27 April 2012 when he was appointed as the Company's full time Chief Financial Officer

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

(i) 31 March

(ii) Enteq - 30 September 2011 (audited interim financial results); and

XXT - 31 December 2011 (audited full year results)

(iii) Financial year to 31 March 2012 - to be published by 30 September 2012; interim period to 30 September 2012 - to be published by 31 December 2012; financial year to 31 March 2013 - to be published by 30 September 2013

 

EXPECTED ADMISSION DATE:

18 May 2012

 

NAME AND ADDRESS OF NOMINATED ADVISER:

Investec Investment Banking, a division of Investec Bank plc

2 Gresham Street

London EC2V 7QP

 

NAME AND ADDRESS OF BROKER:

Investec Investment Banking, a division of Investec Bank plc

2 Gresham Street

London EC2V 7QP

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

The Courtyard

High Street

Ascot

Berkshire

SL5 7HP

 

www.enteq.com

 

The Admission Document will be available from the above website and address and will

contain full details about Enteq Upstream plc and the admission of its securities

 

DATE OF NOTIFICATION:

2 May 2012

 

NEW/ UPDATE:

New

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAALLFIEELIFIIF
Date   Source Headline
10th Apr 20247:00 amRNSYear-end Trading Update
11th Jan 20249:12 amRNSHolding(s) in Company
8th Jan 20243:59 pmRNSHolding(s) in Company
24th Nov 20237:00 amRNSPresenting at the MelloLondon Conference
15th Nov 20237:00 amRNSHalf-year Report
2nd Nov 202310:25 amRNSDirector/PDMR Shareholding
30th Oct 20234:08 pmRNSResult of General Meeting
23rd Oct 20237:00 amRNSAwards under the Enteq Performance Share Plan
18th Oct 202311:07 amRNSInvestor Presentation via Investor Meet Company
10th Oct 20237:00 amRNSAppointment of Non-Executive Director
6th Oct 20232:25 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
29th Sep 20237:00 amRNSAGM Statement and Board Update
22nd Sep 20233:29 pmRNSNotice of Final Results
19th Sep 20232:53 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSNotice of Annual General Meeting
9th Aug 20238:25 amRNSSABER System Field Trial Update
31st Jul 20239:30 amRNSNotice of Final Results
1st Jun 20232:30 pmRNSIssue of Shares and Director/PDMR Shareholdings
1st Jun 20237:00 amRNSAppointment of new CFO
12th Apr 20237:00 amRNSSale of XXT and Year-end Trading Update
29th Mar 20237:08 amRNSSale of Property
15th Feb 20237:00 amRNSSABER Tool Update
16th Nov 20221:25 pmRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSInterim Results
21st Sep 20223:36 pmRNSResult of AGM
21st Sep 20229:05 amRNSSecond Price Monitoring Extn
21st Sep 20229:00 amRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSAGM Trading Statement
2nd Aug 20225:43 pmRNSIssue of Shares and Director/PDMR Shareholding
8th Jul 20223:10 pmRNSDirector/PDMR Shareholding
6th Jul 20227:00 amRNSFinal Results and Investor Presentation
14th Apr 20221:00 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSYear-end Trading Update
8th Mar 20229:06 amRNSHolding(s) in Company
3rd Mar 20221:47 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBusiness Update and SABER Technology Progress
23rd Dec 202110:42 amRNSHolding(s) in Company
15th Dec 20213:39 pmRNSIssue of Shares and Director/PDMR Shareholding
18th Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSExclusive Distributor Agreements Signed
8th Nov 20217:00 amRNSSABER Tool – Field Trial Update
28th Oct 20217:00 amRNSChange of Name
30th Sep 20214:05 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:22 pmRNSResult of General Meeting and Change of Name
23rd Sep 20217:00 amRNSAGM Trading Statement
10th Aug 202110:30 amRNSDirector/PDMR Shareholding
26th Jul 20215:04 pmRNSDirector/PDMR Shareholding
14th Jul 20214:25 pmRNSIssue of shares and Director/PDMR Shareholding
7th Jul 20217:00 amRNSFinal Results & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.